Proficio Capital Partners’s Moderna MRNA Stock Holding History

Proficio Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	+4,251	New	+$220K	0.01%	502
2024 Q4	–	Sell	-3,261	Closed	-$218K	–	373
2024 Q3	$218K	Sell	3,261 -667	-17%	-$61.2K	0.02%	264
2024 Q2	$466K	Buy	3,928 +158	+4%	+$20K	0.05%	173
2024 Q1	$402K	Buy	3,770 +376	+11%	+$37.9K	0.04%	197
2023 Q4	$338K	Sell	3,394 -3	-0.1%	-$252	0.04%	200
2023 Q3	$351K	Buy	+3,397	New	+$379K	0.05%	190
2022 Q1	–	Sell	-979	Closed	-$249K	–	317
2021 Q4	$249K	Sell	979 -13	-1%	-$3.8K	0.03%	253
2021 Q3	$382K	Sell	992 -105	-10%	-$38.7K	0.05%	176
2021 Q2	$258K	Buy	+1,097	New	+$196K	0.03%	237
2019 Q3	–	Sell	-67	Closed	-$1K	–	994
2019 Q2	$1K	Buy	+67	New	+$1.44K	﹤0.01%	1762

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Proficio Capital Partners's MRNA Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in Moderna (MRNA) in Q2 2026: 4,251 shares worth $298K. The stake represents 0.01% of the portfolio and ranks #502 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in MRNA as recently as Q3 2024.

Proficio Capital Partners first reported a position in MRNA in Q2 2019 and has held it in 10 quarters since. The position peaked at $466K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Proficio Capital Partners held 4,251 shares of Moderna worth $298K as of Q2 2026.
Moderna was a new Proficio Capital Partners position in Q2 2026.
Moderna made up 0.01% of Proficio Capital Partners's portfolio in Q2 2026, its #502 holding.
Proficio Capital Partners first reported a position in Moderna in Q2 2019 and has held it in 10 quarters since.
Proficio Capital Partners's Moderna position peaked at $466K in Q2 2024.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.